Resistance/intolerance to second generation TKIs in CML: what to do next?
If resistance occurs to second generation TKIs in chronic myeloid leukemia (CML) patients, what is the next best option? Here, Giuseppe Saglio, MD, of the University of Turin, Turin, Italy, explores t...
Author: VJHemOnc
Added: 09/21/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Chronic Leukemia | Chronic Myeloid Leukaemia | Italy Health | Leukemia